|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Schuler M, Bossy-Wetzel E, Goldstein JC,
Fitzgerald P and Green DR: p53 induces apoptosis by caspase
activation through mitochondrial cytochrome c release. J Biol Chem.
275:7337–7342. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chipuk JE, Maurer U, Green DR and Schuler
M: Pharmacologic activation of p53 elicits Bax-dependent apoptosis
in the absence of transcription. Cancer Cell. 4:371–381. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oda E, Ohki R, Murasawa H, Nemoto J,
Shibue T, Yamashita T, Tokino T, Taniguchi T and Tanaka N: Noxa, a
BH 3-only member of the Bcl-2 family and candidate mediator of
p53-induced apoptosis. Science. 288:1053–1058. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cregan SP, Fortin A, MacLaurin JG,
Callaghan SM, Cecconi F, Yu SW, Dawson TM, Dawson VL, Park DS and
Kroemer G: Apoptosis-inducing factor is involved in the regulation
of caspase-independent cell death. J Cell Biol. 158:507–517. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miyashita T and Reed JC: Tumor suppressor
p53 is a direct transcriptional activator of the human bax gene.
Cell. 80:293–299. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ng LT, Chiang LC, Lin YT and Lin CC:
Antiproliferative and apoptotic effects of tetrandrine on different
human hepatoma cell lines. Am J Chin Med. 34:125–135. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoo SM, Oh SH, Lee SJ, Lee BW, Ko WG, Moon
CK and Lee BH: Inhibition of proliferation and induction of
apoptosis by tetrandrine in HepG2 cells. J Ethnopharmacol.
81:225–229. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He BC, Gao JL, Zhang BQ, Luo Q, Shi Q, Kim
SH, Huang E, Gao Y, Yang K, Wagner ER, Wang L, Tang N, Luo J, Liu
X, Li M, Bi Y, Shen J, Luther G, Hu N, Zhou Q, Luu HH, Haydon RC,
Zhao Y and He TC: Tetrandrine inhibits Wnt/β-catenin signaling and
suppresses tumor growth of human colorectal cancer. Mol Pharmacol.
79:211–219. 2011.
|
|
10
|
Liu C, Gong K, Mao X and Li W: Tetrandrine
induces apoptosis by activating reactive oxygen species and
repressing Akt activity in human hepatocellular carcinoma. Int J
Cancer. 129:1519–1531. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Wang C, Wang H, Wang K, Du Y and
Zhang J: Combination of Tetrandrine with cisplatin enhances
cytotoxicity through growth suppression and apoptosis in ovarian
cancer in vitro and in vivo. Cancer Lett. 304:21–32. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu J, Liu F, Sun M, Sun Z and Sun S:
Enhancement of radiosensitivity and the potential mechanism on
human esophageal carcinoma cells by tetrandrine. Cancer Biother
Radiopharm. 26:437–442. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li X, Zhen D, Lu X, Xu H, Shao Y, Xue Q,
Hu Y, Liu B and Sun W: Enhanced cytotoxicity and activation of
ROS-dependent c-Jun NH2-terminal kinase and caspase-3 by
low doses of tetrandrine-loaded nanoparticles in Lovo cells: a
possible Trojan strategy against cancer. Eur J Pharm Biopharm.
75:334–340. 2010.PubMed/NCBI
|
|
14
|
Arnoult D, Parone P, Mattinou JC,
Antonsson B, Estaquier J and Ameisen JC: Mitochondrial release of
apoptosis-inducing factor occurs downstream of cytochrome c release
in reponse to several proapoptotic stimuli. J Cell Biol.
159:923–929. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Susin SA, Daugas E and Ravagnan L: Two
distinct pathways leading to nuclear apoptosis. J Exp Med.
192:571–580. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li X, Su B, Liu R, Wu D and He D:
Tetrandrine induces apoptosis and triggers caspase cascade in human
bladder cancer cells. J Sur Res. 166:e45–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View
Article : Google Scholar : PubMed/NCBI
|
